Predictive oncology stock.
What this means: Predictive Oncology Inc (POAI) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives POAI a rank of 10. Our methodology considers analysis of the company's financial situation and how it has traded recently. POAI rank of 10 means that it ranks below 90% of stocks.
Common Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares.The average Predictive Oncology stock forecast 2023 represents a 0.36% increase from the last price of $3.08999991416931. For Predictive Oncology stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Predictive Oncology stock forecast of $3.76, a high forecast of $5.03, and a low …Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country.May 26, 2023 · Predictive Oncology (NASDAQ: POAI) is an early-stage AI pharma stock with a differentiated business model. The company owns a biorepository of tumor samples, a lab and a good manufacturing ... The estimated Net Worth of Richard L Gabriel is at least $54.5 Thousand dollars as of 1 September 2020. Mr Gabriel owns over 4,000 units of Predictive Oncology stock worth over $52,142 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $2,333 as Sr. VP of R&D at Predictive Oncology.
What's Happening with POAI Stock Today. Predictive Oncology Inc (POAI) stock has risen 1.56% while the S&P 500 has fallen -0.05% as of 10:07 AM on Thursday, Jun 22. POAI has risen $0.06 from the previous closing price of $3.83 on volume of 25,176 shares. Over the past year the S&P 500 is higher by 16.05% while POAI has fallen -50.82%.
8 Wall Street research analysts have issued 1-year target prices for Kura Oncology's shares. Their KURA share price targets range from $10.50 to $37.00. On average, they predict the company's share price to reach $27.31 in the next twelve months. This suggests a possible upside of 185.7% from the stock's current price.Bank of America says this under-the-radar oncology stock can rally 180%. Published Fri, Aug 11 202311:35 AM EDT Updated Fri, Aug 11 202312:46 PM EDT. Pia Singh @pia_singh_.
For Predictive Oncology stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Predictive Oncology stock forecast of $7.41, a high forecast of $7.95, and a low forecast of $7.1. The average Predictive Oncology stock forecast 2031 represents a 159.26% increase from the last price of $2.85999989509583.Nov 30, 2023 · Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ... EAGAN, Minn., March 16, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that its Board of Directors declared a dividend of one one-thousandth of a share of newly designated Series F Preferred Stock, par value $0.01 per share, for each outstanding share of the Company’s common stock held of record as of 5:00 p ...Predictive Oncology Inc stock performance at a glance. Check Predictive Oncology Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.
Nov 30, 2023 · Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...
Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022
Find real-time POAI - Predictive Oncology Inc stock quotes, company profile, news and forecasts from CNN Business. Stock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.A high-level overview of Predictive Oncology Inc. (POAI) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and …The oncology industry is expected to grow considerably in 2022, driven by the rising occurrence of cancer in the U.S. population. Furthermore, increasing investments by biopharmaceutical companies and the government should fuel the industry's growth. Given the industry's bright growth prospects, Wall Street analysts expect the stocks of …7 brokerages have issued 1 year price targets for ALX Oncology's stock. Their ALXO share price targets range from $10.00 to $34.00. On average, they anticipate the company's stock price to reach $20.42 in the next year. This suggests a possible upside of 154.9% from the stock's current price. View analysts price targets for ALXO or view …Predictive Oncology Inc (POAI) stock is higher by 5.43% while the S&P 500 has fallen -0.81% as of 1:18 PM on Monday, Jan 30. POAI has risen $0.02 from the previous closing price of $0.46 on volume of 290,855 shares. Over the past year the S&P 500 has fallen -10.58% while POAI has fallen -45.45%.Stock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Predictive Oncology : This medical AI innovator has plenty of potential. Duos Technologies ( DUOT ): Duos is a rising tech player that has just surpassed its penny stock status.1. Amgen (AMGN) Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. Amgen stock opened the day at $265.12 after a previous close of $264.59.The estimated Net Worth of Robert L Myers is at least $560 Thousand dollars as of 2 December 2022. Mr Myers owns over 8,795 units of Predictive Oncology stock worth over $232,324 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology.Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. Stock Name. Country.Welcome to Predictive Oncology The leading edge of a new frontier in drug discovery Integrating scientific rigor with machine learning • Overcoming challenges of clinical trials • Improving the probability of success • Collaborating with partners in biopharma • Advancing molecules to medicine with confidence and accuracy Connect with us Changing the game in drug … Home Read More » The Price to Sales ratio or P/S is calculated as price divided by sales. After the P/E ratio, it's one of the most common valuation metrics. If the P/S ratio is 1, that means you're paying $1 for ...
View Predictive Oncology Inc POAI investment & stock information. Get the latest Predictive Oncology Inc POAI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Predictive Oncology “is a data and AI-driven discovery services company that provides predictive models of tumor drug response.” One of Predictive Oncology’s subsidiaries, TumorGenesis ...
IDAI Vs POAI: Stock comparison by Artificial Intelligence. Which is a better buy? Make smart data-driven investment decisions and get unique insights. Start now and save 50% for the first 3 months save 50% for the first 3 months. Ticker. Company. Your search produced no matches. We currently support US stocks and STOXX Europe 600 …Daniel Handley POAI stock SEC Form 4 insiders trading. Daniel has made over 4 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 6,000 units of POAI stock worth $2,460 on 15 December 20226,000 units of POAI stock worth $2,460 on 15 December 2022Aug 16, 2023 · Predictive Oncolog y : Offers a compelling use case for AI in the area of cancer research. Remark ( MARK ): One of the smallest of small-cap stocks may have one of the biggest upsides of any AI stock. Predictive Oncology, Pittsburgh, Pennsylvania. 294 likes. Predictive Oncology (NASDAQ:POAI) Changing the landscape of oncology drug discovery & enabling the deStock analysis for Predictive Oncology Inc (POAI:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Predictive Oncology. POAI. $3.09 ... as of November 29 4:00:00 PM EST. Predictive Oncology (POAI) Stock Price Performance. Predictive Oncology (POAI) Stock Key Data. Summary Additional Data ... For Predictive Oncology stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Predictive Oncology stock forecast of $7.41, a high forecast of $7.95, and a low forecast of $7.1. The average Predictive Oncology stock forecast 2031 represents a 159.26% increase from the last price of $2.85999989509583.Predictive Oncology (NASDAQ:POAI) on Thursday said it would effect a 1-for-20 reverse stock split.The stock split will become effective on April 24. "The reverse stock split is primarily intended ...Real-time quotes, advanced visualizations, historical statements, and much more. Selling, General and Administrative Excl. Other. POAI - Predictive Oncology Inc - Stock screener for investors and traders, financial visualizations.
Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the ...
Complete Predictive Oncology Inc. stock information by Barron's. View real-time POAI stock price and news, along with industry-best analysis.
Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...Against this backdrop, HLGN stock has carved out a place on watch lists this week. Predictive Oncology Inc. (POAI) There is no shortage of excitement around AI stocks. Thanks to the popularity of ChatGPT, there’s been a surge of interest in any company with exposure to the industry.3 analysts have issued 1 year price objectives for Surface Oncology's stock. Their SURF share price targets range from $3.00 to $6.00. On average, they predict the company's share price to reach $4.50 in the next year. This suggests a possible upside of 320.6% from the stock's current price. View analysts price targets for SURF or view …Predictive Oncology CEO Raymond Vennare and Cvergenx CEO Javier Torres-Roca join Natalie Stoberman to share news of their new partnership to develop the first-ever genomics-based approach to precis...The estimated Net Worth of J Melville Engle is at least $117 millier dollars as of 24 May 2022. Mr Engle owns over 159,500 units of Predictive Oncology stock worth over $113,900 and over the last 14 years he sold POAI stock worth over $0. In addition, he makes $3,000 as Chairman & CEO at Predictive Oncology.Predictive Oncology Inc. Weekly Stock List Management's ability to "raise guidance" can often be a catalyst for market-beating returns in the quarters ahead. The third-quarter earnings season is ... Predictive Oncology Inc (NASDAQ: POAI) shares are trading lower by 15.81% to $0.23 Friday morning after the company announced a reverse stock split. What Else? Per an SEC filing, the reverse stock ...TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comCommon Stock Will Begin Trading on Split-Adjusted Basis on April 24, 2023. EAGAN, Minn., April 20, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or the “Company”), today announced that it is effecting a reverse stock split of its common stock at a ratio of 1 post-split share for every 20 pre-split shares.
What's Happening with POAI Stock Today. Predictive Oncology Inc (POAI) stock has risen 1.56% while the S&P 500 has fallen -0.05% as of 10:07 AM on Thursday, Jun 22. POAI has risen $0.06 from the previous closing price of $3.83 on volume of 25,176 shares. Over the past year the S&P 500 is higher by 16.05% while POAI has fallen -50.82%.David Johnson biography. David O. Johnson is Senior Vice President - Operations of Skyline Medical Inc. He was previously the Acting Chief Operating Officer for the Company since December 2011 and had been a consultant to medical device companies since October 2010.Charles Nuzum POAI stock SEC Form 4 insiders trading. Charles has made over 1 trades of the Predictive Oncology stock since 2022, according to the Form 4 filled with the SEC. Most recently Charles bought 200,000 units of POAI stock worth $62,000 on 20 May 2022.200,000 units of POAI stock worth $62,000 on 20 May 2022.COMMON STOCK PURCHASE WARRANT . PREDICTIVE ONCOLOGY INC. Warrant Shares: _____ Initial Exercise Date: February 22, 2021 . ... 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Predictive Oncology Inc., a Delaware corporation ...Instagram:https://instagram. best brokerage account interest ratesprivate equity etfs740i bmwbldp The estimated Net Worth of Robert L Myers is at least $346 Thousand dollars as of 25 September 2023. Mr Myers owns over 1,667 units of Predictive Oncology stock worth over $18,305 and over the last 7 years he sold POAI stock worth over $0. In addition, he makes $327,838 as CFO & Sec. at Predictive Oncology. jnj credovimeo revenue News. Get the latest Predictive Oncology Inc. (POAI) stock news and headlines to help you in your trading and investing decisions. axcella health Insiders trading at Predictive Oncology. Over the last 4 years, insiders at Predictive Oncology have traded over $30,944 worth of Predictive Oncology stock and bought 417,770 units worth $148,589 . The most active insiders traders include Carl I. Schwartz, J Melville Engle, and Charles Lee Sr Nuzum.On average, Predictive …२०२३ जुन २० ... Stock Quotes. Get quotes for stocks: To display multiple quotes,enter symbols with a comma separating each symbol (e.g. F,MSFT,GOOG) ...Nov 8, 2023 · PITTSBURGH, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery and biologics, announced today that it has completed a multi-year study ...